Background: Paternal age related schizophrenia (PARS) has been proposed as a subgroup of
Introduction
The schizophrenias are characterized by significant heterogeneity in symptoms, course of illness, and clinical profiles (Tsuang et al., 1990) . This heterogeneity complicates the interpretation of research findings and inhibits the discovery of novel treatments for the disorder. Some of the variability in symptoms and illness features among schizophrenia patients may be explained by the presence of latent subgroups that differ in etiology and key neurobiological underpinnings.
Identifying these subgroups is important to set the stage for targeted person-specific pharmacological and/or psychological treatments (Jindal et al., 2005) .
Advanced paternal age has been associated with the risk for schizophrenia in cohort studies in Israel Brown et al., 2002) , Denmark, (Byrne et al., 2003) , Sweden (Zammit et al., 2003; Sipos et al., 2004) , Japan (Tsuchiya et al., 2005) , and the United States (Torrey et al., 2009 ). In the Israeli study, a quarter of the risk for schizophrenia was attributable to paternal age and the risk in offspring of fathers aged 50+ at birth was three-fold that of children whose fathers were younger than 25 at birth . Clinical studies have suggested that paternal age related schizophrenia (PARS) may be a specific variant of the disease, as symptom and cognitive profiles, regional cerebral metabolism, sex effects, and heart rate variability have been shown to differ from those of other cases (Malaspina, 2001; Malaspina et al., 2001; 2002a; Rosenfield et al., 2010; Antonius et al., 2010) . If these studies are confirmed, then PARS may account for a substantial portion of the disease in clinical treatment. The confirmation of PARS as a separate group could lead to better understanding of its etiology and pathogenesis, and allow targeted modes of treatment.
Currently, however, it is not clear whether PARS explains any of the heterogeneity of schizophrenia. To explore this, we have chosen to use an approach based on clustering analysis in order to generate new hypotheses related to PARS. Among various clustering techniques, k-means clustering (MacQueen, 1967) has been favored over others (e.g. Yeung et al., 2001; Gibbons & Roth, 2002) , and has been used in schizophrenia research (Richards et al., 2008) . k-means clustering is a partitioning method often used in data mining and machine learning (Huang, 1998; 5 Wagstaff et al., 2001) . It aims to partition, or minimize, the average squared distance between n observations and a cluster centroid, such that each observation is assigned to the cluster with the nearest mean (Hand & Heard, 2005) .
In schizophrenia research, k-means clustering has previously been used to examine the heterogeneity of psychosis symptoms (Mohr et al., 2004) , antipsychotic responses (Garver et al., 2000) , prognostic features (Jonsson & Jonsson, 1992) , and cognitive symptoms (Silver & Shmoish, 2008; Bell et al., 2010) . This clustering approach, however, has not, to our knowledge, been used to examine the distinctiveness of the PARS subgroup.
Methods

Participants:
This study relies on cases with schizophrenia or schizoaffective disorder recruited at the New York State Psychiatric Institute (NYSPI) Schizophrenia Research Unit (SRU) in 1992-2007.
The study was approved by the Institutional Review Board at NYSPI and all patients provided written informed consent.
For our analyses we were interested in a set of core factors consisting of demographic, clinical and cognitive variables. Thus, we included in our analyses only cases on whom we had the following variables: age of onset of psychosis, sex, family history of schizophrenia, age of the father at the case's birth (paternal age), diagnosis, severity of psychopathological symptoms, and neuropsychological function. The specific measures are described below. We operationally defined PARS as the absence of any family history of schizophrenia among first-and second-degree relatives and for cases whose fathers' age at birth was >35 years; all other cases were considered non-PARS (based on Malaspina et al., 2002b) . All cases were taking medication at the time of assessment.
Measures:
Diagnosis was obtained using the Diagnostic Interview for Genetic Studies (DIGS; Nurnberger et al., 1994) . Severity of psychopathology was assessed with the Positive and Negative Syndrome Scale (PANSS; Kay et al., 1987) , which originally was divided into three subscales:
positive, negative and general psychopathology (standard model). More recent research using empirical approaches suggests five factors: positive, negative, activation, dysphoric mood and autistic preoccupation (five-factor model; White et al., 1997) . We included both approaches in our analyses.
The Wechsler Adult Intelligence Scale--Revised (WAIS-R; Wechsler, 1981) was used to obtain the following neuropsychological factors: full scale intelligence quotient (FIQ), verbal IQ (VIQ) and performance IQ (PIQ), as well as the verbal subtests (arithmetic, digit span, information, vocabulary, comprehension, similarities) and the performance subtests (object assembly, picture arrangement, picture completion, digit symbol, block design). We also obtained a verbalperformance differential score (VIQ-PIQ).
In addition to these core measures, we also assessed for the presence of trait markers by evaluating the deficit syndrome (enduring and primary negative symptoms of schizophrenia; Carpenter et al., 1988) with the Schedule for the Deficit Syndrome (SDS; Kirkpatrick et al., 1989) , as well as odor identification (Kopala et al., 2001 ) with the University of Pennsylvania Smell Identification Test (UPSIT; Doty et al., 1984) . The UPSIT is a standardized, multiple-choice, scratchand-sniff test with the maximum score of 40 (perfect identification) that is found to be stable and reliably measured in schizophrenia patients (Malaspina et al., 1994) .
Analysis:
Following MacQueen's (1967) k-means methodology, we used an algorithm in which each item is assigned to the cluster having the nearest centroid (mean). This nonhierarchical method initially takes the number of components of the population equal to the final required number of clusters. The final required number of clusters is chosen such that the points are mutually farthest apart. Next, it examines each component in the population and assigns it to one of the clusters depending on the minimum distance. The centroid's position is recalculated every time a component 7 is added to the cluster and this continues until all the components are grouped into the final required number of clusters. The process is composed of the following three steps: 1) partition the items into k initial clusters; 2) proceed through the list of items, assigning an item to the cluster whose centroid is nearest (we used Euclidean distance as the measure of distance). Then, recalculate the centroid for the cluster receiving the new item and for the cluster losing the item; 3) repeat Step 2 until no more reassignment takes place.
The above described k-means clustering algorithm was run using various combinations of variables in order to identify latent subgroups of PARS. The clusters were generated using the following core variables: age of onset of psychosis, sex (males = 0; females = 1), family history (no family history of schizophrenia = 0; family history of schizophrenia = 1) and paternal age (age of the father at the case's birth). Together with these variables we added one of two sets of variables, or a combination of them. These two sets of variables were: the WAIS-R FIQ, PIQ, VIQ, VIQ-PIQ and the verbal and performance subtests; and the PANSS scores from the standard model (positive, negative, and general psychopathology subscale scores).
The analysis was performed with SAS version 9.2 (SAS Institute, Cary, NC) proc fastclus. In contrast to other clustering methods (e.g. hierarchical clustering) there is no standard way to find the optimal number of clusters; thus we ran numerous analyses with various values of k (from k=2 to k=12 for the above described two sets of variables), with the goal of finding clusters with high concentrations of PARS subjects.
Results
Two of our k-means clustering analyses produced clusters with high PARS concentration.
Each of the two clustering analyses generated seven clusters (k=7) and yielded some prominent features related to the PARS subjects. The first analysis included the 11 WAIS-R subtests in addition to the four core demographic variables (age of onset of psychosis, sex, paternal age, family history of schizophrenia). The second analysis included the VIQ-PIQ variable and the PANSS factors from the standard model (positive, negative and general psychopathology symptoms) 8 together with the same four core demographic variables used in the first analysis. The descriptive data for the demographic, clinical and neuropsychological variables from these two analyses are presented in tables 1 and 2.
For each variable included in the clustering analysis, we conducted a two-sample t-test for continuous variables and a chi-square test for categorical variables for a comparison between a specific cluster and the rest of the data. The data are expressed as the mean ± standard error of the mean. The means (and standard deviation; SD) are presented in tables 3 and 4. A two-sided pvalue ≤0.05 is considered significant for all analyses. Table 3 shows the first analysis, which included 136 cases, 34 (25.0%) of which were PARS.
Among the clusters, Cluster 3 (N=24) contained 20 PARS cases (83%). This cluster had a higher average differential score between VIQ and PIQ (VIQ-PIQ) than the rest of the sample (12.9±2.3 vs.
6.3±1.0, p=0.009). Also, the mean paternal and maternal ages were relatively high at 41 and 33 years, respectively.
Although less relevant to our main focus on PARS, table 3 displays some other significant results
1
. Compared to the rest of the data, Cluster 1 had more familial cases (p=0.004), lower average UPSIT score (p=0.039), higher proportion of deficit syndrome cases (p=0.009), lower neuropsychological scores (p<0.0001), and higher PANSS (standard model) subscale scores (all p<0.005). Cluster 2 showed higher scores on block design, object assembly and digit symbol scores (p=0.003, 0.013 and 0.001, respectively) compared to the rest of the data. Cluster 4 and Cluster 5 demonstrated higher FIQ, VIQ, PIQ and most of the WAIS-R subtest scores than the rest of the data.
The standard model PANSS subscales were lower in Cluster 5 than the rest of the data (all p<0.05), but no difference was observed in Cluster 4. Clusters 5 and 6 consisted of only males with early age onset of psychosis and these cases had higher PIQ scores than VIQ scores.
The second analysis yielded 123 cases of which 30 (24.4%) were PARS. This analysis is shown in table 4. Cluster 2 produced the highest proportion of PARS with 10 out of 14 cases (71%; these were all sporadic patients). Inspection of the data revealed that the majority of the cases in this Cluster were also in Cluster 3 in the first analysis discussed above. Interestingly, compared to 9 the other clusters, the Cluster 2 cases were mostly females (93% vs. 35% females, p<0.0001) with earlier age of onset of psychosis (17.2±1.7 vs. 22.4±0.6, p=0.006). The mean paternal age was higher in the Cluster 2 group (39.3; SD=8.8) than the rest of the data. None of the Cluster 2 cases had the deficit syndrome, and the neuropsychological scores and the PANSS scores for this group were not significantly different from those in the other groups.
From the other significant results in table 4 1 , Cluster 1 had a higher proportion of males (p=0.001), more schizophrenia than schizoaffective cases (p=0.018), lower mean UPSIT score (p=0.006), higher proportion of deficit syndrome cases (p<0.0001), lower main WAIS-R scores (FIQ: p=0.025; PIQ: p=0.030; VIQ: p=0.031), lower standard scale PANSS positive symptoms (p=0.0005), and higher standard scale PANSS negative symptoms (p<0.0001) compared to the rest of the data.
Cluster 3 contained 100% male cases with a larger difference between VIQ and PIQ scores than the rest of the data (p<0.0001). This is due to the low mean PIQ score, which is the lowest among the 7 clusters (p=0.019). Cluster 4 demonstrated lower paternal age (p=0.003), higher FIQ, VIQ and PIQ scores (all p≤0.02), and lower standard PANSS negative and general psychopathology scores (p<0.0001) than the rest of the data. Additionally, this is the only group with lower mean VIQ than PIQ. Cluster 5 consisted of 100% females with a later onset of psychosis (p<0.0001), higher UPSIT score (p=0.007), more familial cases (p=0.0003), and lower standard PANSS symptom subscales (all p<0.01) than the rest of the data. Cluster 6 had a higher proportion of females than the rest of the data (p=0.0005). Cluster 7 showed earlier onset of psychosis (p=0.008), higher proportion of males (p=0.018), more familial cases (p=0.003), and lower FIQ (p=0.010) and VIQ (p=0.001) than the rest of the data. Both Cluster 6 and Cluster 7 had no deficit syndrome cases, and they had higher PANSS standard positive and general symptoms scales (p<0.0001) than the rest of the data.
It should be noted that in the first cluster analysis, the 34 PARS cases were distributed as follows: Cluster 1 (N=5), Cluster 2 (3), Cluster 3 (20), Cluster 4 (2), Cluster 5 (2), Cluster 6 (1) and Cluster 7 (1). In the second cluster analysis, the 30 PARS patients were distributed as follows:
Cluster 1 (N=1), Cluster 2 (10), Cluster 3 (9), Cluster 4 (3), Cluster 5 (3), Cluster 6 (2) and Cluster 7 (2). Additionally, the 20 PARS cases in the Cluster 3 group of the first analysis were 10 males and 10 10 females. Among these, three cases were excluded in the second analysis due to missing PANSS scores. Of the remaining 17 PARS cases, most belong to Cluster 2 and Cluster 3, depending on their sex. Cluster 3 contained six male cases, whereas five females and one male were in Cluster 2.
The remaining five PARS cases were distributed as follows: Cluster 1 (one male), Cluster 5 (two females) and Cluster 6 (two females).
Due to missing data points on some of the core measures, certain cases were only captured in the first clustering analysis (N=16; 8 males and 8 females), and some cases were only captured in the second analysis (N=3; 2 males and 1 female). 120 (70 males; 50 females) of the cases were captured in both clustering analyses. See supplementary data for the descriptive data for the cases that overlap (are both in analysis 1 and 2) and for the cases that are either only in analysis 1 or 2.
Discussion
This study employed k-means clustering analyses to examine if specific illness features of schizophrenia are associated with later paternal age. We identified PARS cases that clustered in groups with particular characteristics. One group was characterized by a greater differential between verbal and performance intelligence, and the other group showed a high concentration of female cases and significant early onset of psychosis.
Our first clustering analysis, which considered demographic variables and neuropsychological test score variables, showed a cluster containing 83% PARS cases. It was characterized by relatively high paternal age (mean age = 41 years). The mean maternal age (33 years) was also relatively high in this cluster group. Interestingly, the cases in this group demonstrated a significant difference between the WAIS-R verbal and performance intelligence, with verbal functioning being on average 12.97 points better.
The verbal versus performance IQ decrement is notable. The result is driven by better performance on all the verbal subtasks (arithmetic, digit span, information, vocabulary, comprehension, similarities) compared to the performance subtasks (object assembly, picture 11 arrangement, picture completion, digit symbol, block design). This result supports previous findings in other populations showing a strong relationship between older fathers and human intelligence (Auroux et al., 1989; Malaspina et al., 2005) . These data also replicate previous findings from the same population (Malaspina et al., 2002b) , despite using a different method of analysis, suggesting reductions in non-verbal intelligence compared to verbal intelligence in cases with older paternal age. The fact that paternal age has a larger effect on performance intelligence than verbal intelligence may be of interest. Future research that examines intelligence together with other cognitive and neurological symptoms would be valuable in further determining the distinctiveness of PARS as a subgroup of schizophrenia.
Our second separate k-means clustering analysis, which included the VIQ-PIQ discrepancy score, the PANSS standard subscale scores and the same demographic variables, revealed a cluster consisting of 71% PARS cases. This cluster had a significantly higher concentration of females and demonstrated an earlier age of psychosis onset. These findings show that later paternal age may have a particularly strong influence on the symptoms and clinical characteristics of female PARS cases in comparison with other female cases. A high risk of schizophrenia for females of older fathers was recently reported by Perrin et al (2010) . Females of an affected sister born to fathers 35 years and older had a fourfold greater risk of schizophrenia than females with an affected sister born to fathers <35 years at time of birth. By contrast the risk of schizophrenia in males with an affected brother was only doubled for older versus younger fathers. They proposed that paternally expressed genes on the X chromosome could play a role in the risk associated with females of an affected sister born to older fathers.
A non-significant discrepancy (6.21 points) between the verbal and performance intelligence was evident in the high-concentration PARS group in the second analysis. The reduction in discrepancy from the first analysis may not be surprising as we included the VIQ-PIQ discrepancy score as a factor in the second cluster analysis. The reduction may also be partly explained by gender separation in this cluster. As discussed above, 12 of the PARS cases from Cluster 3 in the first analysis were sorted into Cluster 2 (five females and one male) and Cluster 3 (six males) in the second analysis. The mean VIQ-PIQ of these 12 subjects was 11.8, and it was reduced in Cluster 2 (mean VIQ-PIQ of the six patients was 6.17), while it was increased in Cluster 3 (mean VIQ-PIQ of the six patients was 17.5). The PANSS scores revealed similar results as found in the first cluster analysis.
The strengths of this study include the use of a statistical method that is particularly germane for resolving the heterogeneity of schizophrenia. k-means clustering analyses require variability in numerous factors to generate separate independent clusters that share common attributes. Moreover, k-means clustering analysis assures minimal variation within the clusters, but maximum variation between the clusters, creating more homogeneous subgroups. Our results show that etiological data and clinical information can both be considered in the procedures.
It should be noted that our total PARS sample size for the k-means clustering analysis was relatively small. In the first analysis we had a total of 34 PARS cases, with 20 PARS cases belonging to the high PARS concentration cluster. The second analysis only included 30 PARS cases, with 10 cases being in the high PARS concentration cluster. Future studies that screen for higher inclusion rates of PARS cases may be successful in recruiting larger PARS samples. Such studies may also want to include variables not examined here but found to be of etiological significance.
In summary, our findings demonstrate that k-means clustering analysis may be a useful statistical method to explore the heterogeneous nature of schizophrenia symptoms and to examine the relationships between etiological, clinical and cognitive symptoms in PARS subgroups. The results provide further evidence that the genetic and neurobiological underpinnings of schizophrenia associated with the illness risk attributable to later paternal age may be different than that of other cases. This method may be particularly helpful in establishing the phenotype of PARS, and in generating new hypotheses that will help in the development of novel clinical treatment approaches to the variability of symptoms in PARS patients.
